ID   GNMT_HUMAN              Reviewed;         295 AA.
AC   Q14749; Q5T8W2; Q9NNZ1; Q9NS24;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 161.
DE   RecName: Full=Glycine N-methyltransferase;
DE            EC=2.1.1.20;
GN   Name=GNMT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9495250;
RX   DOI=10.1002/(SICI)1097-0215(19980302)75:5<787::AID-IJC20>3.0.CO;2-2;
RA   Chen Y.-M.A., Shiu J.Y., Tzeng S.J., Shih L.S., Chen Y.J., Lui W.Y.,
RA   Chen P.H.;
RT   "Characterization of glycine-N-methyltransferase-gene expression in
RT   human hepatocellular carcinoma.";
RL   Int. J. Cancer 75:787-793(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=10843803; DOI=10.1006/geno.2000.6188;
RA   Chen Y.-M.A., Chen L.-Y., Wong F.H., Lee C.M., Chang T.J.,
RA   Yang-Feng T.L.;
RT   "Genomic structure, expression, and chromosomal localization of the
RT   human glycine N-methyltransferase gene.";
RL   Genomics 66:43-47(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 31-295.
RX   PubMed=8281755;
RA   Ogawa H., Gomi T., Fujioka M.;
RT   "Mammalian glycine N-methyltransferases. Comparative kinetic and
RT   structural properties of the enzymes from human, rat, rabbit and pig
RT   livers.";
RL   Comp. Biochem. Physiol. 106B:601-611(1993).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 2-294, SUBUNIT, AND
RP   FUNCTION.
RX   PubMed=15340920; DOI=10.1002/prot.20209;
RA   Pakhomova S., Luka Z., Grohmann S., Wagner C., Newcomer M.E.;
RT   "Glycine N-methyltransferases: a comparison of the crystal structures
RT   and kinetic properties of recombinant human, mouse and rat enzymes.";
RL   Proteins 57:331-337(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1-294, SUBUNIT, FUNCTION, AND
RP   CHARACTERIZATION OF VARIANT GNMT DEFICIENCY ASN-177.
RX   PubMed=17660255; DOI=10.1110/ps.072921507;
RA   Luka Z., Pakhomova S., Luka Y., Newcomer M.E., Wagner C.;
RT   "Destabilization of human glycine N-methyltransferase by H176N
RT   mutation.";
RL   Protein Sci. 16:1957-1964(2007).
RN   [10]
RP   VARIANTS GNMT DEFICIENCY PRO-50 AND ASN-177.
RX   PubMed=11810299; DOI=10.1007/s00439-001-0648-4;
RA   Luka Z., Cerone R., Phillips J.A. III, Mudd S.H., Wagner C.;
RT   "Mutations in human glycine N-methyltransferase give insights into its
RT   role in methionine metabolism.";
RL   Hum. Genet. 110:68-74(2002).
RN   [11]
RP   CHARACTERIZATION OF VARIANTS GNMT DEFICIENCY PRO-50; SER-141 AND
RP   ASN-177.
RX   PubMed=14651980; DOI=10.1016/j.bbrc.2003.11.037;
RA   Luka Z., Wagner C.;
RT   "Effect of naturally occurring mutations in human glycine N-
RT   methyltransferase on activity and conformation.";
RL   Biochem. Biophys. Res. Commun. 312:1067-1072(2003).
RN   [12]
RP   VARIANT GNMT DEFICIENCY SER-141.
RX   PubMed=14739680; DOI=10.1023/B:BOLI.0000009978.17777.33;
RA   Augoustides-Savvopoulou P., Luka Z., Karyda S., Stabler S.P.,
RA   Allen R.H., Patsiaoura K., Wagner C., Mudd S.H.;
RT   "Glycine N-methyltransferase deficiency: a new patient with a novel
RT   mutation.";
RL   J. Inherit. Metab. Dis. 26:745-759(2003).
CC   -!- FUNCTION: Catalyzes the methylation of glycine by using S-
CC       adenosylmethionine (AdoMet) to form N-methylglycine (sarcosine)
CC       with the concomitant production of S-adenosylhomocysteine
CC       (AdoHcy). Possible crucial role in the regulation of tissue
CC       concentration of AdoMet and of metabolism of methionine.
CC       {ECO:0000269|PubMed:15340920, ECO:0000269|PubMed:17660255}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + glycine = S-
CC       adenosyl-L-homocysteine + sarcosine.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15340920,
CC       ECO:0000269|PubMed:17660255}.
CC   -!- INTERACTION:
CC       P49407:ARRB1; NbExp=7; IntAct=EBI-744239, EBI-743313;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Abundant in liver.
CC   -!- DISEASE: Glycine N-methyltransferase deficiency (GNMT deficiency)
CC       [MIM:606664]: The only clinical abnormalities in patients with
CC       this deficiency are mild hepatomegaly and chronic elevation of
CC       serum transaminases. {ECO:0000269|PubMed:11810299,
CC       ECO:0000269|PubMed:14739680}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding
CC       methyltransferase superfamily. Glycine N-methyltransferase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00932}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF101477; AAF78290.1; -; mRNA.
DR   EMBL; AF101475; AAF78289.1; -; Genomic_DNA.
DR   EMBL; AL158815; CAI19462.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04124.1; -; Genomic_DNA.
DR   EMBL; BC032627; AAH32627.1; -; mRNA.
DR   EMBL; X62250; CAA44164.1; -; mRNA.
DR   CCDS; CCDS4876.1; -.
DR   PIR; S42627; S42627.
DR   RefSeq; NP_001305794.1; NM_001318865.1.
DR   RefSeq; NP_061833.1; NM_018960.5.
DR   UniGene; Hs.144914; -.
DR   PDB; 1R74; X-ray; 2.55 A; A/B=2-295.
DR   PDB; 2AZT; X-ray; 2.70 A; A/B=1-295.
DR   PDBsum; 1R74; -.
DR   PDBsum; 2AZT; -.
DR   ProteinModelPortal; Q14749; -.
DR   SMR; Q14749; -.
DR   BioGrid; 118081; 19.
DR   IntAct; Q14749; 18.
DR   MINT; MINT-1436683; -.
DR   STRING; 9606.ENSP00000361894; -.
DR   DrugBank; DB04272; Citric Acid.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB01752; S-Adenosyl-L-Homocysteine.
DR   DrugBank; DB00118; S-Adenosylmethionine.
DR   iPTMnet; Q14749; -.
DR   PhosphoSitePlus; Q14749; -.
DR   BioMuta; GNMT; -.
DR   DMDM; 12644416; -.
DR   PaxDb; Q14749; -.
DR   PeptideAtlas; Q14749; -.
DR   PRIDE; Q14749; -.
DR   DNASU; 27232; -.
DR   Ensembl; ENST00000372808; ENSP00000361894; ENSG00000124713.
DR   GeneID; 27232; -.
DR   KEGG; hsa:27232; -.
DR   CTD; 27232; -.
DR   DisGeNET; 27232; -.
DR   GeneCards; GNMT; -.
DR   HGNC; HGNC:4415; GNMT.
DR   HPA; HPA027501; -.
DR   MalaCards; GNMT; -.
DR   MIM; 606628; gene.
DR   MIM; 606664; phenotype.
DR   neXtProt; NX_Q14749; -.
DR   OpenTargets; ENSG00000124713; -.
DR   Orphanet; 289891; Hypermethioninemia due to glycine N-methyltransferase deficiency.
DR   PharmGKB; PA28794; -.
DR   eggNOG; ENOG410IF1C; Eukaryota.
DR   eggNOG; ENOG410ZWXN; LUCA.
DR   GeneTree; ENSGT00390000006845; -.
DR   HOGENOM; HOG000276537; -.
DR   HOVERGEN; HBG051748; -.
DR   InParanoid; Q14749; -.
DR   KO; K00552; -.
DR   OMA; MITLDYT; -.
DR   OrthoDB; EOG091G0J3Z; -.
DR   PhylomeDB; Q14749; -.
DR   TreeFam; TF324814; -.
DR   BRENDA; 2.1.1.20; 2681.
DR   Reactome; R-HSA-2408508; Metabolism of ingested SeMet, Sec, MeSec into H2Se.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   SABIO-RK; Q14749; -.
DR   EvolutionaryTrace; Q14749; -.
DR   GeneWiki; GNMT; -.
DR   GenomeRNAi; 27232; -.
DR   PRO; PR:Q14749; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000124713; -.
DR   CleanEx; HS_GNMT; -.
DR   ExpressionAtlas; Q14749; baseline and differential.
DR   Genevisible; Q14749; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005542; F:folic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0016594; F:glycine binding; IDA:UniProtKB.
DR   GO; GO:0017174; F:glycine N-methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; NAS:UniProtKB.
DR   GO; GO:0005977; P:glycogen metabolic process; IEA:Ensembl.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   GO; GO:0006555; P:methionine metabolic process; IEA:Ensembl.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:Ensembl.
DR   GO; GO:0051289; P:protein homotetramerization; IPI:UniProtKB.
DR   GO; GO:0006111; P:regulation of gluconeogenesis; IEA:Ensembl.
DR   GO; GO:0046500; P:S-adenosylmethionine metabolic process; IDA:UniProtKB.
DR   InterPro; IPR014369; Gly/Sar_N_MeTrfase.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   PANTHER; PTHR16458; PTHR16458; 1.
DR   PIRSF; PIRSF000385; Gly_N-mtase; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   PROSITE; PS51600; SAM_GNMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Disease mutation; Folate-binding; Methyltransferase; Phosphoprotein;
KW   Reference proteome; S-adenosyl-L-methionine; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P13255}.
FT   CHAIN         2    295       Glycine N-methyltransferase.
FT                                /FTId=PRO_0000087524.
FT   REGION      117    118       S-adenosyl-L-methionine binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00932}.
FT   BINDING      22     22       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00932}.
FT   BINDING      31     31       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00932}.
FT   BINDING      34     34       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00932}.
FT   BINDING      41     41       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00932}.
FT   BINDING      65     65       S-adenosyl-L-methionine; via carbonyl
FT                                oxygen. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00932}.
FT   BINDING      86     86       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00932}.
FT   BINDING     139    139       S-adenosyl-L-methionine; via carbonyl
FT                                oxygen. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00932}.
FT   BINDING     141    141       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00932}.
FT   BINDING     178    178       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00932}.
FT   BINDING     223    223       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00932}.
FT   MOD_RES       2      2       N-acetylvaline.
FT                                {ECO:0000250|UniProtKB:P13255}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QXF8}.
FT   MOD_RES      34     34       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9QXF8}.
FT   MOD_RES      46     46       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9QXF8}.
FT   MOD_RES     193    193       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9QXF8}.
FT   MOD_RES     198    198       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9QXF8}.
FT   MOD_RES     203    203       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9QXF8}.
FT   VARIANT      50     50       L -> P (in GNMT deficiency; 10% wild-type
FT                                activity; dbSNP:rs121907888).
FT                                {ECO:0000269|PubMed:11810299,
FT                                ECO:0000269|PubMed:14651980}.
FT                                /FTId=VAR_012766.
FT   VARIANT     141    141       N -> S (in GNMT deficiency; 0.5% wild-
FT                                type activity; dbSNP:rs864321678).
FT                                {ECO:0000269|PubMed:14651980,
FT                                ECO:0000269|PubMed:14739680}.
FT                                /FTId=VAR_019840.
FT   VARIANT     177    177       H -> N (in GNMT deficiency; 75% wild-type
FT                                activity, decreases stability of the
FT                                tetramer; dbSNP:rs121907889).
FT                                {ECO:0000269|PubMed:11810299,
FT                                ECO:0000269|PubMed:14651980,
FT                                ECO:0000269|PubMed:17660255}.
FT                                /FTId=VAR_012767.
FT   CONFLICT    119    119       Missing (in Ref. 6; CAA44164).
FT                                {ECO:0000305}.
FT   CONFLICT    129    130       AE -> PK (in Ref. 2; AAF78289).
FT                                {ECO:0000305}.
FT   CONFLICT    175    175       I -> S (in Ref. 6; CAA44164).
FT                                {ECO:0000305}.
FT   CONFLICT    256    260       LLQAA -> SPSS (in Ref. 6; CAA44164).
FT                                {ECO:0000305}.
FT   TURN         21     24       {ECO:0000244|PDB:1R74}.
FT   HELIX        28     34       {ECO:0000244|PDB:1R74}.
FT   HELIX        43     55       {ECO:0000244|PDB:1R74}.
FT   STRAND       60     64       {ECO:0000244|PDB:1R74}.
FT   HELIX        70     78       {ECO:0000244|PDB:1R74}.
FT   STRAND       81     87       {ECO:0000244|PDB:1R74}.
FT   HELIX        89    101       {ECO:0000244|PDB:1R74}.
FT   TURN        102    104       {ECO:0000244|PDB:1R74}.
FT   HELIX       106    109       {ECO:0000244|PDB:1R74}.
FT   STRAND      112    115       {ECO:0000244|PDB:1R74}.
FT   HELIX       118    120       {ECO:0000244|PDB:1R74}.
FT   HELIX       121    124       {ECO:0000244|PDB:1R74}.
FT   STRAND      133    138       {ECO:0000244|PDB:1R74}.
FT   HELIX       143    145       {ECO:0000244|PDB:1R74}.
FT   STRAND      150    153       {ECO:0000244|PDB:1R74}.
FT   HELIX       154    165       {ECO:0000244|PDB:1R74}.
FT   STRAND      167    178       {ECO:0000244|PDB:1R74}.
FT   HELIX       180    186       {ECO:0000244|PDB:1R74}.
FT   STRAND      195    197       {ECO:0000244|PDB:1R74}.
FT   STRAND      204    212       {ECO:0000244|PDB:1R74}.
FT   STRAND      215    225       {ECO:0000244|PDB:1R74}.
FT   STRAND      239    245       {ECO:0000244|PDB:1R74}.
FT   HELIX       250    260       {ECO:0000244|PDB:1R74}.
FT   TURN        261    263       {ECO:0000244|PDB:1R74}.
FT   STRAND      265    271       {ECO:0000244|PDB:1R74}.
FT   STRAND      285    293       {ECO:0000244|PDB:1R74}.
SQ   SEQUENCE   295 AA;  32742 MW;  34F4546136FD27ED CRC64;
     MVDSVYRTRS LGVAAEGLPD QYADGEAARV WQLYIGDTRS RTAEYKAWLL GLLRQHGCQR
     VLDVACGTGV DSIMLVEEGF SVTSVDASDK MLKYALKERW NRRHEPAFDK WVIEEANWMT
     LDKDVPQSAE GGFDAVICLG NSFAHLPDCK GDQSEHRLAL KNIASMVRAG GLLVIDHRNY
     DHILSTGCAP PGKNIYYKSD LTKDVTTSVL IVNNKAHMVT LDYTVQVPGA GQDGSPGLSK
     FRLSYYPHCL ASFTELLQAA FGGKCQHSVL GDFKPYKPGQ TYIPCYFIHV LKRTD
//
